SECOR Capital Advisors, LP - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 118 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
SECOR Capital Advisors, LP ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$346,000
+22.7%
62,495
+96.0%
0.04%
+45.2%
Q3 2018$282,000
-84.0%
31,889
-81.9%
0.03%
-79.5%
Q2 2018$1,759,000
+164.5%
176,219
+152.6%
0.15%
+174.5%
Q1 2018$665,000
-7.6%
69,749
+44.0%
0.06%
+89.7%
Q4 2017$720,000
+142.4%
48,435
+50.3%
0.03%
-9.4%
Q1 2017$297,000
-17.3%
32,233
-6.5%
0.03%
-27.3%
Q4 2016$359,00034,4890.04%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders